Seeking men and women who have been hospitalized with COVID-19 for a study that compares the safety and activity of experimental regimens consisting of oral anti-inflammatory agents plus Remdesivir.
We are studying whether oral anti-inflammatory drugs (baricitinib OR dexamethasone) administered with remdesivir are safe and effective when administered to people hospitalized with COVID-19. Half of the people in this trial will get a combination of baricitinib and remdesivir and half will get a combination of dexamethasone and remdesivir.
What we're hoping for
This study will evaluate and compare the safety of two combination regimens (oral anti-inflammatory drugs, baricitinib OR dexamethasone, and remdesivir), as well whether they are helpful in speeding recovery of people hospitalized with COVID-19.
ClinicalTrials.gov Identifier: NCT04640168